Showing results (2501-2510 of 2,892) with videos related to

Sort By:
Pageof 290
JACC. Advances|June 28, 2024
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 DiabetesRozalina G McCoy, Kavya Sindhu Swarna, Yihong Deng, et al.
Thyroid : Official Journal of the American Thyroid Association|June 5, 2013
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosisDonald S A McLeod, David S Cooper, Paul W Ladenson, et al.
The Annals of Thoracic Surgery|October 10, 2018
Surgical Atrial Fibrillation Ablation Improves Long-Term Survival: A Multicenter AnalysisAlexander Iribarne, Anthony W DiScipio, Jock N McCullough, et al.
The Oncologist|May 22, 2022
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung CancerKarthikeyan Murugesan, Dexter X Jin, Leah A Comment, et al.
Journal of the American Heart Association|February 18, 2020
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims DataSanket S Dhruva, Craig S Parzynski, Ginger M Gamble, et al.
Nature Reviews. Urology|March 28, 2023
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.
JCO Precision Oncology|July 12, 2022
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting TherapiesAmado J Zurita, Ryon P Graf, Guillermo Villacampa, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
The Oncologist|August 16, 2018
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation BurdenWinnie S Liang, Jo-Anne Vergilio, Bodour Salhia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Pageof 290